|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 969.00 GBX | +1.47% |
|
+0.73% | -9.94% |
| Feb. 10 | Analyst recommendations: Drax, AstraZeneca, HSBC, Broadcom, Tesla... |  |
| Feb. 10 | Analyst recommendations: Aspen, Amazon, Mattel, Broadcom, Tesla… | |
| Capitalization | 843M 1.06B 1.01B 954M 1.51B 92.05B 1.67B 11.36B 4.21B 38.49B 3.98B 3.9B 162B | P/E ratio 2025 * |
15.8x | P/E ratio 2026 * | 13.1x |
|---|---|---|---|---|---|
| Enterprise value | 854M 1.08B 1.03B 967M 1.53B 93.3B 1.69B 11.51B 4.27B 39.01B 4.04B 3.96B 164B | EV / Sales 2025 * |
2.81x | EV / Sales 2026 * | 2.62x |
| Free-Float |
98.36% | Yield 2025 * |
6.21% | Yield 2026 * | 6.24% |
More valuation ratios
* Estimated data
More news
Last Transcript: Victrex plc
More recommendations
More press releases
More news
| 1 day | +1.47% | ||
| 1 week | +0.73% | ||
| Current month | -2.32% | ||
| 1 month | -3.49% | ||
| 3 months | +14.40% | ||
| 6 months | -4.44% | ||
| Current year | -9.94% |
1 week
938.00
998.00
1 month
938.001 080.00
Current year
938.001 092.00
1 year
816.001 390.00
3 years
816.002 014.00
5 years
816.002 720.00
10 years
816.003 438.06
| Director | Title | Age | Since |
|---|---|---|---|
Jakob Sigurðsson
CEO | Chief Executive Officer | 61 | 2017-09-30 |
Michael Ward
DFI | Director of Finance/CFO | - | - |
Ian Melling
DFI | Director of Finance/CFO | - | 2022-07-03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jane Toogood
BRD | Director/Board Member | - | 2015-08-31 |
Jakob Sigurðsson
BRD | Director/Board Member | 61 | 2017-09-30 |
Janet Ashdown
BRD | Director/Board Member | 66 | 2018-02-08 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 0 M€ | -3.35% | - | |
| 0% | 54 M€ | +4.73% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.47% | +0.73% | -28.91% | -51.06% | 1.04B | ||
| -0.27% | +7.01% | +22.02% | +44.74% | 75.17B | ||
| +0.71% | +4.76% | -1.14% | -18.24% | 42.64B | ||
| +2.92% | +5.43% | +10.45% | +13.22% | 40.23B | ||
| +0.67% | +2.57% | +2.28% | +25.40% | 24.71B | ||
| -0.68% | +3.96% | +4.79% | -28.19% | 17.08B | ||
| -1.70% | +3.81% | +2.55% | -1.41% | 14.82B | ||
| -2.24% | -1.06% | +9.16% | +66.19% | 13.54B | ||
| -3.83% | +0.05% | -4.38% | -39.96% | 11.47B | ||
| +0.33% | +4.05% | +15.61% | -31.69% | 9.59B | ||
| Average | -0.26% | +1.77% | +3.24% | -2.10% | 25.03B | |
| Weighted average by Cap. | +0.15% | +3.18% | +9.57% | +13.28% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 303M 383M 364M 344M 542M 33.15B 602M 4.09B 1.52B 13.86B 1.43B 1.41B 58.19B | 323M 407M 388M 366M 577M 35.29B 640M 4.35B 1.61B 14.76B 1.53B 1.5B 61.94B |
| Net income | 53.06M 66.91M 63.69M 60.07M 94.79M 5.8B 105M 715M 265M 2.42B 251M 246M 10.17B | 64.49M 81.32M 77.42M 73.02M 115M 7.04B 128M 869M 322M 2.95B 305M 299M 12.37B |
| Net Debt | 11.46M 14.45M 13.75M 12.97M 20.47M 1.25B 22.71M 154M 57.22M 523M 54.15M 53.06M 2.2B | 4.04M 5.1M 4.86M 4.58M 7.23M 442M 8.02M 54.53M 20.2M 185M 19.12M 18.73M 776M |
More financial data
* Estimated data
Employees
1,131
Sector
Specialty Chemicals
Calendar
2025-05-18
- Q2 2025 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-02-14 | 969.00 p | +1.47% | 67,568 |
| 25-02-13 | 955.00 p | -0.10% | 81,399 |
| 25-02-12 | 956.00 p | +0.21% | 88,323 |
| 25-02-11 | 954.00 p | -1.95% | 130,157 |
| 25-02-10 | 973.00 p | +1.14% | 80,151 |
Delayed Quote London S.E., February 14, 2025 at 11:35 am EST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
9.690GBP
Average target price
12.56GBP
Spread / Average Target
+29.63%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VCT Stock